Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human NK cells: From development to effector functions
Arosh S. Perera Molligoda Arachchige
Innate Immunity (2021) Vol. 27, Iss. 3, pp. 212-229
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Qiaofei Liu, Jiayi Li, Huaijin Zheng, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 67
Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults
Sathyabaarathi Ravichandran, Fernando Erra Díaz, Emin Onur Karakaslar, et al.
Nature Immunology (2024) Vol. 25, Iss. 2, pp. 316-329
Open Access | Times Cited: 16
The Chicken Embryo Model: A Novel and Relevant Model for Immune-Based Studies
Paul Garcia, Yan Wang, Jean Viallet, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 72
Advances in NK cell production
Fang Fang, Siqi Xie, Minhua Chen, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 4, pp. 460-481
Open Access | Times Cited: 67
In ovo model in cancer research and tumor immunology
Lea Miebach, Julia Berner, Sander Bekeschus
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 42
Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer
Mona M. Elanany, Dina Mostafa, Nadia Μ. Hamdy
Life Sciences (2023) Vol. 330, pp. 121997-121997
Closed Access | Times Cited: 41
Cereulide and Emetic Bacillus cereus: Characterizations, Impacts and Public Precautions
Shuo Yang, Yating Wang, Yangtai Liu, et al.
Foods (2023) Vol. 12, Iss. 4, pp. 833-833
Open Access | Times Cited: 36
From immunology to artificial intelligence: revolutionizing latent tuberculosis infection diagnosis with machine learning
Linsheng Li, Ling Yang, Zhuang Li, et al.
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 28
Unraveling the dynamic mechanisms of natural killer cells in viral infections: insights and implications
Arash Letafati, Omid Salahi Ardekani, Mina Naderisemiromi, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 15
The role of CD56bright NK cells in neurodegenerative disorders
Carla Rodriguez-Mogeda, Chaja M. J. van Ansenwoude, Lennart van der Molen, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Tumor Microenvironment: A Niche for Cancer Stem Cell Immunotherapy
Mia C. Borlongan, Dipongkor Saha, Hongbin Wang
Stem Cell Reviews and Reports (2023) Vol. 20, Iss. 1, pp. 3-24
Closed Access | Times Cited: 19
Beyond lymphopenia, unraveling radiation-induced leucocyte subpopulation kinetics and mechanisms through modeling approaches
Thao-Nguyen Pham, Julie Coupey, Serge M. Candéias, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 18
Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)
Qian Li, Geneviève Marcoux, Yuefen Hu, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 12, pp. 103677-103677
Closed Access | Times Cited: 7
The role of exhausted natural killer cells in the immunopathogenesis and treatment of leukemia
Asal Barshidi, Keivan Ardeshiri, Farbod Ebrahimi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Alternative CAR Therapies: Recent Approaches in Engineering Chimeric Antigen Receptor Immune Cells to Combat Cancer
Carlos M. Moreno, Christopher Haynie, Abigail Cheever, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1493-1493
Open Access | Times Cited: 25
Current state of NK cell-mediated immunotherapy in chronic lymphocytic leukemia
Zonghan Wang, Wei Li, Hao Dong, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 13
Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we?
Mohammad Hossein Razizadeh, Alireza Zafarani, Mahsa Taghavi-Farahabadi, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Gastric Cancer Signaling Pathways and Therapeutic Applications
Mingfang Wu, Shiman Yuan, Kai Liu, et al.
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access | Times Cited: 5
Natural killer cells in sepsis: Friends or foes?
Fangjie Wang, Yiqin Cui, Dongmei He, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
The emergence of DNAM-1 as the facilitator of NK cell-mediated killing in ovarian cancer
Rachel Pounds, Wayne Croft, Hayden Pearce, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
CD63 as a potential biomarker for patients with ovarian cancer
Keiichiro Nakamura, Naoyuki Ida, Akira Hirasawa, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology (2025) Vol. 306, pp. 87-93
Closed Access
Breast cancer stroma and its components: Implication in diagnostic and therapeutic
Riya Sharma, Pankaj Kumar, Vijay Kumar, et al.
Elsevier eBooks (2025), pp. 43-68
Closed Access
Review on gene and cell therapies in prostate cancer treatment: prospects and challenges
Oboma Yibala Ibor, Bassey Ekpenyong, Arun Kumar M, et al.
Journal of Translational Genetics and Genomics (2025) Vol. 9, Iss. 2, pp. 62-75
Open Access
Decreased surface receptors, function, and suboptimal osteoclasts-induced cell expansion in natural killer (NK) cells of elderly subjects
Kawaljit Kaur, Anahid Jewett
Aging (2025)
Open Access
Supercharged NK cells, unlike primary activated NK cells, effectively target ovarian cancer cells irrespective of MHC-class I expression
Sara Huerta-Yepez, Po-Chun Chen, Kawaljit Kaur, et al.
BMJ Oncology (2025) Vol. 4, Iss. 1, pp. e000618-e000618
Open Access
Page 1 - Next Page

Scroll to top